Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LifeCor, now a division of ZOLL Medical Corporation, is a medical technology company best known for developing the LifeVest, the first wearable cardioverter defibrillator (WCD). The LifeVest is designed to continuously monitor a patient's heart rhythm and automatically deliver a treatment shock if a life-threatening arrhythmia is detected. This technology provides protection for patients at high risk of sudden cardiac arrest, particularly those recovering from a heart attack or living with heart failure. Since its acquisition, the company has continued to refine its wearable monitoring and defibrillation technology to improve patient outcomes in cardiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LifeCor.